SNHG1 and hepatocellular carcinoma: Researchers found that the translocation of miR-21 to the nucleus induced by Sorafenib could promote SNHG1 expression by binding to SNHG1 and promoting its transcription in HCC cells [101] (Tables 1, 2, 3, 4).